How New Data From IAS 2017 May Inform Use of ART in Patients With Cardiovascular or Bone Comorbidities
NEAT 022: Switch From Boosted PI–Based ART to Dolutegravir-Based ART Maintains Virologic Suppression, Improves Lipid Profile in Virologically Suppressed Patients With High CVD Risk
Contemporary Management of HIV: New Data From IAS 2017
Clinical Impact of New Data From IAS 2017
Key Studies Influencing My Practice Following IAS 2017
Clinical Care Options, LLC. All Rights Reserved.